China Universal Asset Management Co., Ltd. Rhythm Pharmaceuticals, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.03 Billion
- Q4 2024
A detailed history of China Universal Asset Management Co., Ltd. transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 13,031 shares of RYTM stock, worth $772,998. This represents 0.07% of its overall portfolio holdings.
Number of Shares
13,031
Previous 11,758
10.83%
Holding current value
$772,998
Previous $616,000
18.18%
% of portfolio
0.07%
Previous 0.07%
Shares
15 transactions
Others Institutions Holding RYTM
# of Institutions
189Shares Held
67.1MCall Options Held
834KPut Options Held
78.6K-
Primecap Management CO Pasadena, CA7.22MShares$428 Million0.28% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$400 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY6.4MShares$380 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$361 Million4.44% of portfolio
-
Goldman Sachs Group Inc New York, NY3.88MShares$230 Million0.03% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.31B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...